Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deza

Showing results (321-330 of 351) with videos related to

Pageof 36
Sort By:
Dermatology (Basel, Switzerland)|May 31, 2023
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS StudyVerónica Ruiz-Salas, Sebastian Podlipnik, Alejandra Sandoval-Clavijo, et al.
Actas Dermo-Sifiliograficas|April 23, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|June 11, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Environment International|December 25, 2022
Mapping the evidence of the effects of environmental factors on the prevalence of antibiotic resistance in the non-built environment: Protocol for a systematic evidence mapBrian Gardner, Martha Betson, Adriana Cabal Rosel, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppressionSofia Bruni, Florencia L Mauro, Cecilia J Proietti, et al.
Vaccine|April 4, 2024
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trialAsrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, et al.
Hormones & Cancer|July 8, 2020
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good PrognosisSantiago Madera, María F Chervo, Violeta A Chiauzzi, et al.
Neuron|May 20, 2026
ATF2 phosphorylation is a core transcriptional driver of neuron apoptosisJorge Gómez-Deza, Matthew Nebiyou, Lara H El Touny, et al.
Journal of the American Academy of Dermatology|March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort studyIgnasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Human Vaccines & Immunotherapeutics|December 5, 2024
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 studyMartira Maddeppungeng, Asrawati Nurdin, Yetty Movieta Nency, et al.
Pageof 36

Showing results (321-330 of 351) with videos related to

Sort By:
Pageof 36
Dermatology (Basel, Switzerland)|May 31, 2023
Real-World Experience with Vismodegib on Advanced and Multiple BCCs: Data from the RELIVIS StudyVerónica Ruiz-Salas, Sebastian Podlipnik, Alejandra Sandoval-Clavijo, et al.
Actas Dermo-Sifiliograficas|April 23, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Actas Dermo-Sifiliograficas|June 11, 2023
Sonidegib as a Locally Advanced Basal Cell Carcinoma Therapy in Real-life Clinical Setting: A National Multicentre StudyO M Moreno-Arrones, S Béa-Ardebol, F Mayo-Martinez, et al.
Environment International|December 25, 2022
Mapping the evidence of the effects of environmental factors on the prevalence of antibiotic resistance in the non-built environment: Protocol for a systematic evidence mapBrian Gardner, Martha Betson, Adriana Cabal Rosel, et al.
Journal for Immunotherapy of Cancer|March 8, 2023
Blocking soluble TNFα sensitizes HER2-positive breast cancer to trastuzumab through MUC4 downregulation and subverts immunosuppressionSofia Bruni, Florencia L Mauro, Cecilia J Proietti, et al.
Vaccine|April 4, 2024
Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trialAsrawati Nurdin, Yetty Movieta Nency, Martira Maddeppungeng, et al.
Hormones & Cancer|July 8, 2020
Nuclear PDCD4 Expression Defines a Subset of Luminal B-Like Breast Cancers with Good PrognosisSantiago Madera, María F Chervo, Violeta A Chiauzzi, et al.
Neuron|May 20, 2026
ATF2 phosphorylation is a core transcriptional driver of neuron apoptosisJorge Gómez-Deza, Matthew Nebiyou, Lara H El Touny, et al.
Journal of the American Academy of Dermatology|March 12, 2023
Prognostic factors for satellitosis or in-transit metastasis in cutaneous squamous cell carcinoma: A multicentric cohort studyIgnasi Marti-Marti, Sebastian Podlipnik, Javier Cañueto, et al.
Human Vaccines & Immunotherapeutics|December 5, 2024
Safety and immunogenicity of a SARS-CoV-2 recombinant protein subunit vaccine adjuvanted with Alum + CpG 1018 in healthy Indonesian adults: A multicenter, randomized, comparative, observer-blind, placebo-controlled phase 2 studyMartira Maddeppungeng, Asrawati Nurdin, Yetty Movieta Nency, et al.
Pageof 36